The 5 Most Hated Biotechs: Myriad, Sarepta, OncoMed, VIVUS, and MannKind

33 %
67 %
Information about The 5 Most Hated Biotechs: Myriad, Sarepta, OncoMed, VIVUS, and MannKind
Investor Relations

Published on March 13, 2014

Author: TheMotleyFool

Source: slideshare.net

Description

The five companies with the largest number of shares sold short as a percentage of float.

Add a comment

Related presentations

Related pages

The 5 Most Hated Biotechs: Myriad, Sarepta, OncoMed, VIVUS ...

The 5 Most Hated Biotechs: Myriad, Sarepta, OncoMed, ... OMED ) , VIVUS (NASDAQ: VVUS ) , and MannKind (NASDAQ: ... 5.74 0.03% S&P 500: 2,083.39 ...
Read more

The 5 Most Hated Biotechs: Myraid, Sarepta, Questcor ...

... and MannKind top the list of the most shorted biotechs. ... The 5 Most Hated Biotechs: Myraid, Sarepta, Questcor, ... not to Myriad Genetics)
Read more

Myriad | LinkedIn

View 114605 Myriad posts, presentations, experts, and more. Get the professional knowledge you need on LinkedIn. LinkedIn Home What is LinkedIn? Join Today
Read more

OncoMed | Cafepharma

The 5 Most Hated Biotechs: Myriad, Sarepta, OncoMed, VIVUS, and MannKind. The 5 Most Hated Biotechs: Myriad, Sarepta, OncoMed, VIVUS, ... Vivus. MannKind ...
Read more

3 bursting biotech stocks -- 1 to buy

1. 3 Bursting Biotech Stocks – 1 to Buy Source: Achillion Pharma 2. 1. Zafgen, Inc. (NASDAQ: ZFGN) Zafgen, Inc. is a clinical stage biotechnology company ...
Read more

What You Need to Know About iPhone 6

Leaked! Everything You Need To Know About the Upcoming iPhone 6 All Your iPhone 6 News in One Place • In the following slideshow, we have collected all ...
Read more

Vivus News & Analysen | finanzen.at

Vivus News & Analysen: Hier finden Sie die News & Analysen-Seite für den Wert Vivus. Benutzername (E-Mail) Passwort. Registrieren? Fan werden; finanzen.at ...
Read more

Adam Feuerstein's Biotech Blog - TheStreet

To participate in Adam's "Biotech Stock Mailbag," please send your ... the most closely followed biotech sector ... MannKind's inhaled ...
Read more